Ocaliva Approved for Rare Liver Disease - HealthDay

MarketWatch

Ocaliva Approved for Rare Liver Disease HealthDay TUESDAY, May 31, 2016 (HealthDay News) -- Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat a rare chronic liver disease called primary biliary cholangitis (PBC). The disease causes the liver's small bile ... Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a yearMarketWatch FDA approves Ocaliva for rare, chronic liver diseaseFDA.gov New Primary Biliary Cholangitis Treatment ApprovedPharmacy Times PharmaLive (press release) (subscription) -The Pharma Letter (registration) all 8 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNE47fI8pwrTvnct--nSDtEH2IIXNA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779124130223&ei=w9pNV5i_EsTD3QHcrrXQDQ&url=https://consumer.healthday.com/diseases-and-conditions-information-37/liver-disease-news-447/ocaliva-approved-for-rare-liver-disease-711476.html
via IFTTT